Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells

J Biochem. 2024 Mar 4;175(3):313-322. doi: 10.1093/jb/mvad105.

Abstract

The cystine/glutamate transporter SLC7A11/xCT is highly expressed in many cancer cells and plays an important role in antioxidant activity by supplying cysteine for glutathione synthesis. Under glucose-depleted conditions, however, SLC7A11-mediated cystine uptake causes oxidative stress and cell death called disulfidptosis, a new form of cell death. We previously reported that high cell density (HD) promotes lysosomal degradation of SLC7A11 in glioblastoma cells, allowing them to survive under glucose-depleted conditions. In this study, we found that the neurofibromatosis type 2 gene, Merlin/NF2 is a key regulator of SLC7A11 in glioblastoma cells at HD. Deletion of Merlin increased SLC7A11 protein level and cystine uptake at HD, leading to promotion of cell death under glucose deprivation. Furthermore, HD significantly decreased SLC7A11 mRNA level, which was restored by Merlin deletion. This study suggests that Merlin suppresses glucose deprivation-induced cell death by downregulating SLC7A11 expression in glioblastoma cells at HD.

Keywords: amino acid transport; cell death; cell density; glioblastoma; transcriptional regulation.

MeSH terms

  • Amino Acid Transport System y+ / genetics
  • Cell Count
  • Cell Survival
  • Cystine
  • Glioblastoma*
  • Glucose
  • Humans
  • Neurofibromin 2*

Substances

  • Neurofibromin 2
  • Cystine
  • Glucose
  • SLC7A11 protein, human
  • Amino Acid Transport System y+